Driven by ambition to ensure universal health coverage and acknowledging that 70% of medical decisions hinge on diagnostics, healthcare providers seek accessible, speedy, precise, and cost-effective diagnostic solutions. This impetus led Genient to pioneer the development and education of advanced Genomics and Immunology technologies.

Leveraging deep genomics, syndrome-oriented design, extensive multiplexing, and input from clinicians, Genient assays emerge as the favored choice for detecting multiple disease states, biomarkers, and pathogens using minimal samples and achieving rapid turnaround times. The capability to utilize various bodily fluids in multiplex configurations empowers this cutting-edge technology to furnish clinicians with high-quality data swiftly, expediting treatment procedures—an embodiment of "Access to Healthcare."

Research stands as the cornerstone of diagnostics, a catalyst for uncovering future innovations. Infectious diseases have historically plagued our global community, claiming millions of lives through their rapid and ever-changing nature. Progress in scientific capabilities, such as sequencing technologies, predictive modeling of mutations, and mathematically-driven drug designs, holds the promise of anticipating upcoming threats and offering insights for vaccine and drug development.

Genient offers consultancy services encompassing research design, product development, and comprehensive post-analysis to bolster the efforts of physicians, researchers, and all stakeholders combatting cancer, non-communicable diseases (NCDs), pharmacogenomics, and emerging pathogens. A critical facet in advancing healthcare involves addressing environmental factors, including implementing food safety regulations and ensuring the security of crops through GMO and plant pathogen testing. Genient provides genomic solutions aimed at delivering safe, pathogen-free food from large-scale manufacturing plants while enhancing genetic research in plant sciences.

Genient, in collaboration with international partners specializing in Fertility Solutions, holds the forefront position as the primary provider in IVF and reproductive genetics, delivering groundbreaking products and services tailored for every phase of the ART process. Our vision for accessible health envisions a world where women, infants, and families thrive in good health. We offer access to a global consortium of esteemed scientific minds, embryologists, and experts in clinical training, providing comprehensive services ranging from complete ART/IVF center setups to offering essential products (reagents & instruments) crucial for IVF procedures.